Welcome to LookChem.com Sign In|Join Free

CAS

  • or

25769-61-3

Post Buying Request

25769-61-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

25769-61-3 Usage

Uses

Glycolic Anhydride Diacetate, is the product of reaction involving Lead tetraacetate as an oxidizing agent It is also an intermediate in the synthesis of Chrysogine, a metabolite of Penicillium chrysogenum and some related 2-substituted 4-(3H)-quinazolinones.

Check Digit Verification of cas no

The CAS Registry Mumber 25769-61-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,5,7,6 and 9 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 25769-61:
(7*2)+(6*5)+(5*7)+(4*6)+(3*9)+(2*6)+(1*1)=143
143 % 10 = 3
So 25769-61-3 is a valid CAS Registry Number.

25769-61-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name (2-acetyloxyacetyl) 2-acetyloxyacetate

1.2 Other means of identification

Product number -
Other names Acetoxyacetic anhydride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:25769-61-3 SDS

25769-61-3Relevant articles and documents

Pyridylmethylthio derivatives as VEGF inhibitors: Part 2

Tajima, Hisashi,Honda, Takahiro,Kawashima, Kenji,Sasabuchi, Yoshimasa,Yamamoto, Minoru,Ban, Masakazu,Okamoto, Kazuyoshi,Inoue, Kenji,Inaba, Takaaki,Takeno, Yuriko,Tsuboi, Takashi,Tonouchi, Asaka,Aono, Hiroyuki

supporting information; experimental part, p. 1232 - 1235 (2011/04/16)

Optimization of compounds 5 and 6 led to the discovery of VEGF inhibitor 10g which reduced CYP inhibition. It was highly active in vitro (VEGF induced HUVEC proliferation assay) and showed efficacies in three disease models in vivo (cancer, RA, and AMD).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 25769-61-3